Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.Rainmed Medical Limited润迈德医疗有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 2297) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 28 2024 Reference is made to the circular (the “Circular”) of Rainmed Medical Limited (the “Company”) and notice of the Annual General Meeting (the “Notice”) both dated April 30 2024. Unless otherwise stated capitalized terms used herein shall have the same meanings as those defined in the Circular.The Board is pleased to announce the Annual General Meeting was held on Friday June 28 2024 and all the proposed resolutions set out in the Notice were duly passed by the Shareholders by way of poll.The poll results in respect of the resolutions passed at the Annual General Meeting are as follows: Number of Votes ORDINARY RESOLUTIONS (approximate percentage (%)) For Against 1. To receive consider and adopt the audited consolidated 460648000 0 financial statements of the Company and its subsidiaries and 100% 0% the reports of the Directors and the auditor of the Company for the year ended December 31 2023. 2. (a) To re-elect the following retiring Directors: (i) Mr. Huo Yunfei as an executive Director; 460648000 0 100%0% (ii) Mr. Lyu Yonghui as an executive Director; 460648000 0 100%0% (iii) Ms. Gu Yang as an executive Director; and 460648000 0 100%0% (iv) Mr. Chen Xuefeng as an independent non- 460648000 0 executive Director. 100% 0% (b) To authorize the Board to fix the remuneration of 460648000 0 the Directors. 100% 0% 1Number of Votes ORDINARY RESOLUTIONS (approximate percentage (%)) For Against 3. To re-appoint SHINEWING (HK) CPA Limited as 460648000 0 the auditor of the Company to hold office until the 100% 0% conclusion of the next annual general meeting of the Company and to authorize the Board to fix its remuneration for the year ending December 31 2024. 4. (A) To grant a general mandate to the Directors to 460648000 0 allot issue and deal with additional shares of the 100% 0% Company as set out in the resolution numbered 4(A) of the Notice#. (B) To grant a general mandate to the Directors to 460648000 0 repurchase shares of the Company as set out in the 100% 0% resolution numbered 4(B) of the Notice#. (C) To extend the general mandate granted to the 460648000 0 Directors to allot issue and deal with shares of the 100% 0% Company by the number of shares repurchased by the Company as set out in the resolution numbered 4(C) of the Notice#. Number of Votes SPECIAL RESOLUTION (approximate percentage (%)) For Against 5. To approve the proposed amendments to the existing 460648000 0 third amended and restated memorandum and articles 100% 0% of association of the Company and to adopt the fourth amended and restated memorandum and articles of association of the Company#.# The full text of above resolutions are set out in the Notice.As more than 50% of votes were cast in favour of each of the resolutions numbered 1 to 4 above all of the above ordinary resolutions were duly passed at the Annual General Meeting. As more than 75% of votes were cast in favour of the resolution numbered 5 above the above special resolution was duly passed at the Annual General Meeting. 2As at the date of the Annual General Meeting the total number of issued Shares were 1167799000 Shares which was the total number of Shares entitling the Shareholders to attend and vote on the resolutions proposed at the Annual General Meeting. There were no Shares entitling the Shareholders to attend and abstain from voting in favour of any of the resolutions at the Annual General Meeting as set out in Rule 13.40 of the Listing Rules.No Shareholder was required under the Listing Rules to abstain from voting on any of the resolutions at the Annual General Meeting. None of the Shareholders has stated any intention in the Circular to vote against or to abstain from voting on any of the resolutions proposed at the Annual General Meeting.All Directors have attended the Annual General Meeting in person or via electronic means.Tricor Investor Services Limited the Company’s Hong Kong branch share registrar acted as the scrutineer for the vote-taking at the Annual General Meeting.By order of the Board Rainmed Medical Limited Huo Yunfei Chairman of the Board and Executive Director Hong Kong June 28 2024 As at the date of this announcement the Board comprises Mr. Huo Yunfei Mr. Lyu Yonghui Mr. Zhang Liang and Ms. Gu Yang as executive Directors Mr. Wang Lin and Mr. Heng Lei as non-executive Directors and Mr. Liu Shuen Kong Mr. Li Ho Man and Mr. Chen Xuefeng as independent non-executive Directors. 3